The Georgia Access to Medical Cannabis Commission has awarded provisional Class 2 production licence contracts for low-THC oil production to four more companies.
The licenses have been awarded to FFD GA Holdings LLC, TheraTrue Georgia, LLC, Natures GA, LLC, and Treevana Remedy Inc.
Each company will now be permitted to produce low-THC products in the state, which will dramatically expand access for patients.
Sid Johnson, Chair of the Commission, stated: “We are pleased to announce this major expansion of access to medical cannabis for patients in Georgia. With a total of six licensed production companies, patients will have more opportunities to access medical relief closer to home.
“The number of dispensaries licensed by the Commission could soon increase from nine to thirty, making medical relief reachable to patients who are not able to travel due to their medical conditions.”
Following a litigation filed by certain companies that did not fall into the bracket of highest-scoring applicants, the awarding of the Class 2 production licenses had been delayed.
The Georgia Access to Medical Cannabis Commission has stated that, in light of recent judicial decisions, including recent decisions by the Georgia Court of Appeals, the Commission determined it was in the best interest of patients to move forward with these provisional contract awards.
“The number of lawsuits that may continue to be filed are uncertain,” Chair Johnson said. “However, the need for low-THC oil and products as medical treatment and relief for patients in Georgia is certain.”
“Everything we have done is for the patients and patient access. We appreciate the support and patience for the work of the Commission as we worked through the required processes,” added Andrew Turnage, Executive Director of the GMCC.
“We look forward to partnering with these four new companies to expand patient access to safe, laboratory tested, and well-regulated medical cannabis in Georgia.”
